salvag chemotherapi patient germ cell tumor memori sloan-kett cancer center experi germ cell tumor gct patient success platin-bas induct regimen durabl complet respons CR aliv median follow-up month analysi prognost factor respons surviv patient salvag chemotherapi surviv and/or respons therapi patient prior CR chemotherapi treatment cisplatin-bas salvag regimen testi primari site normal serum human chorion gonadotropin level normal serum lactat dehydrogenas level site metastasi indiana class patient prior incomplet respons IR poor prognosi patient aliv median follow-up month patient prior respons CR median follow-up month poor surviv patient durabl CR chemotherapi warrant continu investig new salvag therapi identif prognost featur salvag therapi aid interpret clinic trial salvag regimen 